Literature DB >> 12788204

Causative and susceptibility genes for Alzheimer's disease: a review.

A Rocchi1, S Pellegrini, G Siciliano, L Murri.   

Abstract

Alzheimer's disease (AD) is the most common type of dementia in the elderly population. Three genes have been identified as responsible for the rare early-onset familial form of the disease: the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene and the presenilin 2 (PSEN2) gene. Mutations in these genes, however, account for less than 5% of the total number of AD cases. The remaining 95% of AD patients are mostly sporadic late-onset cases, with a complex aetiology due to interactions between environmental conditions and genetic features of the individual. In this paper, we review the most important genes supposed to be involved in the pathogenesis of AD, known as susceptibility genes, in an attempt to provide a comprehensive picture of what is known about the genetic mechanisms underlying the onset and progression of AD. Hypotheses about the role of each gene in the pathogenic pathway are discussed, taking into account the functions and molecular features, if known, of the coded protein. A major susceptibility gene, the apolipoprotein E (APOE) gene, found to be associated with sporadic late-onset AD cases and the only one, whose role in AD has been confirmed in numerous studies, will be included in a specific chapter. As the results reported by association studies are conflicting, we conclude that a better understanding of the complex aetiology that underlies AD may be achieved likely through a multidisciplinary approach that combines clinical and neurophysiological characterization of AD subtypes and in vivo functional brain imaging studies with molecular investigations of genetic components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788204     DOI: 10.1016/s0361-9230(03)00067-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  79 in total

1.  Haplotype information and linkage disequilibrium mapping for single nucleotide polymorphisms.

Authors:  Xin Lu; Tianhua Niu; Jun S Liu
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

2.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease.

Authors:  Chaoshun Zuo; Zhiyi Zuo
Journal:  Dement Geriatr Cogn Disord       Date:  2010-04-06       Impact factor: 2.959

4.  Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.

Authors:  Joel Kowalewski; Claire Murphy
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

5.  Linkage of monogenic infantile hypertrophic pyloric stenosis to chromosome 16p12-p13 and evidence for genetic heterogeneity.

Authors:  Francesca Capon; Ashley Reece; Rathi Ravindrarajah; Eddie Chung
Journal:  Am J Hum Genet       Date:  2006-06-07       Impact factor: 11.025

6.  Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients.

Authors:  Suman Lal; Edwin Sandanaraj; Srinivasa Rao Jada; Ming-Chai Kong; Lai-Heng Lee; Boon-Cher Goh; Soo-Chin Lee; Balram Chowbay
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

7.  Genetic counseling throughout the life cycle.

Authors:  Leslie J Ciarleglio; Robin L Bennett; Jennifer Williamson; Jessica B Mandell; Joan H Marks
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

9.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Authors:  Trevor D Burt; Brian K Agan; Vincent C Marconi; Weijing He; Hemant Kulkarni; Jeffrey E Mold; Marielle Cavrois; Yadong Huang; Robert W Mahley; Matthew J Dolan; Joseph M McCune; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

10.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.